Administrado por nuestras enfermeras practicantes con licencia
Follow us on Social media : Facebook pages : Instagram: Asmarahope Follow us for new offers , deals , updates and new on coming services & Treatments
Although several GLP-1 receptor agonists exist, this article focuses specifically on semaglutide, the most widely used option
Clinical trial data shows that burping rates vary by drug and dose: Ozempic injection (semaglutide): Burping reported in 3% of patients at the 0.5 mg dose and 1% of patients at the 1 mg dose Wegovy injection (semaglutide): Burping reported in 7% of adults at the 2.4 mg dose Mounjaro and Zepbound (tirzepatide): Burping reported in 25% of patients across doses (Source: Drugs.com) These numbers likely underestimate real-world prevalence, as sulfur burps are often underreported in clinical trials or described under broader terms like belching or eructation. Some patients avoid mentioning it to their doctors out of embarrassment, as well
While tirzepatide does not have absolute dietary restrictions, clinical experience and patient reports consistently identify specific food categories that commonly trigger or worsen gastrointestinal side effects
Thomas Garvey, a former FDA official and drug industry consultant who has testified against McNeil in trials, called the amount of time the FDA had taken to reach a final ruling remarkable and unusual. There are still many questions about this drug, Garvey said
